KPTI 主要統計
高い
7.16
オープン
7.14
取引高
148.62K
低い
6.88
前日終値
7.18
売買代金
1.04M
52週高値
10.99
相対取引高
0.228
変動幅 (%)
3.83%
52週安値
3.65
売買回転率
0.66%
時価総額
162.71M
PER（TTM）
--
PER（年次）
--
PBR
-0.61
PSR
1.08
1株当たり利益（EPS）
-15.087
配当（TTM）
0
配当利回り
0.00%
発行済株式数
22.66M
通貨単位
USD
KPTI 価格パフォーマンス
7 日
30 日
90 日
180 日
年初来
1 年
KPTI マネーフロー分布
KPTI 日次空売り出来高
KPTI ショートインタレスト履歴
KPTI 株式スナップショット
As of 2026-07-23, the Karyopharm Therapeutics Inc. (KPTI) stock price today is 6.98. Based on this price, the company has a market capitalization of $162.71M, with a P/E ratio of --.
On 2026-07-23, KPTI traded between 6.88 and 7.16. Today’s stock price is 1.45% above the daily low and 2.51% below the daily high, placing KPTI 低めの範囲に its most recent trading range.
Trading volume currently stands at 148.62K, compared with an average daily volume of 652.80K. This suggests that trading activity is 通常水準を大きく下回る than usual.
Over the past year, Karyopharm Therapeutics Inc. shares have traded between 3.65 and 10.99. At today’s price, KPTI is 91.23% above its 52-week low and 36.49% below its 52-week high.
KPTI 関連ニュース
について KPTI
企業名
Karyopharm Therapeutics Inc.
セクター
Health Technology
業種
Pharmaceuticals: Major
取引所
Nasdaq
従業員数
228
ロットサイズ
100
公式サイト
通貨単位
USD
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Related Stocks
